← Open Payments lookup

INNA SABIRZHANOVA: Open Payments

NPI 1750061479 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$371 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $371

Food & beverage: $371
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$99
Janssen Biotech, Inc.3$87
Bayer Healthcare Pharmaceuticals Inc.2$55
Incyte Corporation2$52
E.R. Squibb & Sons, L.L.C.1$23
Janssen Scientific Affairs, LLC1$19
Daiichi Sankyo Inc.1$19
Merck Sharp & Dohme LLC1$17

Products named: TECVAYLI, Stivarga, TALVEY, OPDIVO, KEYTRUDA.

Industry payments across MD — which companies pay providers there.